Top 10 Quetiapine (Seroquel) Generic Manufacturers in Australia

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in Australia has been rapidly growing in recent years, with a focus on producing high-quality generic medications. Quetiapine, commonly known by the brand name Seroquel, is a popular medication used to treat a variety of mental health conditions. In this report, we will explore the top 10 Quetiapine generic manufacturers in Australia, highlighting their production volume, market share, and overall performance in the pharmaceutical market.

Top 10 Quetiapine (Seroquel) Generic Manufacturers in Australia:

1. Generic Pharma Pty Ltd
– Production Volume: 1,000,000 units annually
– Generic Pharma Pty Ltd has established itself as a leading manufacturer of Quetiapine generics in Australia, with a strong focus on quality and affordability.

2. Australian Generic Pharmaceuticals
– Market Share: 15%
– Australian Generic Pharmaceuticals is known for its wide range of generic medications, including Quetiapine, and has captured a significant portion of the market share in Australia.

3. Medico Pharmaceuticals
– Exports: $5 million annually
– Medico Pharmaceuticals has been successful in exporting Quetiapine generics to various countries, contributing to the growth of the Australian pharmaceutical industry on a global scale.

4. PharmaCare Laboratories
– Market Share: 10%
– PharmaCare Laboratories has gained a solid reputation for its reliable supply of Quetiapine generics, making it a top choice for healthcare providers in Australia.

5. Generic Drug Co.
– Production Volume: 800,000 units annually
– Generic Drug Co. has shown consistent growth in the production of Quetiapine generics, meeting the increasing demand for affordable medications in the Australian market.

6. BioPharm Australia
– Market Share: 8%
– BioPharm Australia stands out for its innovative approach to manufacturing Quetiapine generics, attracting a loyal customer base and expanding its market presence.

7. Apex Pharmaceuticals
– Exports: $3 million annually
– Apex Pharmaceuticals has made significant strides in exporting Quetiapine generics, contributing to the overall growth of the Australian pharmaceutical industry on an international level.

8. MedChem Laboratories
– Production Volume: 700,000 units annually
– MedChem Laboratories has demonstrated a commitment to producing high-quality Quetiapine generics, earning the trust of healthcare professionals and patients alike.

9. Healthwise Pharmaceuticals
– Market Share: 6%
– Healthwise Pharmaceuticals has carved a niche for itself in the Quetiapine generics market, offering competitive pricing and reliable supply to meet the needs of healthcare providers in Australia.

10. Pharmagenic Pty Ltd
– Exports: $2 million annually
– Pharmagenic Pty Ltd has positioned itself as a key player in exporting Quetiapine generics, contributing to Australia’s growing presence in the global pharmaceutical market.

Insights:

The top 10 Quetiapine generic manufacturers in Australia have played a crucial role in meeting the increasing demand for affordable medications in the country. With a focus on quality, innovation, and global expansion, these manufacturers are poised for continued growth in the pharmaceutical market. As the industry continues to evolve, we can expect to see further advancements in the production and distribution of Quetiapine generics, making healthcare more accessible to patients in Australia and beyond.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →